Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Impact of preoperative anemia on relapse and survival in breast cancer patients

Figure 4

LRFS, LNMFS, DMFS, RFS, and OS for patients in stage II with and without anemia. A. LRFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage II. B. LNMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage II. C. DMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage II. D. RFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage II. E. OS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage II.

Back to article page
\